Novartis AG (NVS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Novartis AG, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 19.02x | 16.45x | 14.12x | 26.92x | 7.73x | 25.21x |
| P/B Ratio | 5.79x | 4.46x | 4.49x | 3.16x | 2.74x | 3.60x |
| P/S Ratio | 4.88x | 3.80x | 4.50x | 4.31x | 4.22x | 4.08x |
| Profitability | ||||||
| Gross Margin | 75.0% | 75.2% | 73.3% | 73.4% | 73.3% | 69.7% |
| Operating Margin | 31.2% | 28.1% | 20.9% | 18.3% | 22.9% | 20.3% |
| Net Margin | 25.6% | 23.1% | 31.8% | 16.0% | 54.6% | 16.2% |
| EBITDA Margin | 41.9% | 40.1% | 39.1% | 33.8% | 70.3% | 34.5% |
| Liquidity | ||||||
| Current Ratio | 1.12x | 1.04x | 1.16x | 1.29x | 1.51x | 0.90x |
| Quick Ratio | 0.89x | 0.84x | 0.93x | 1.04x | 1.29x | 0.68x |
| Leverage | ||||||
| Debt/Equity | 0.80x | 0.71x | 0.56x | 0.47x | 0.46x | 0.67x |
YoY = year-over-year change. Source: FMP..